BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8247254)

  • 1. The effect of salt-loading on corticotropin releasing hormone and arginine vasopressin mRNA levels in the mouse hypothalamus: a quantitative in situ hybridization analysis.
    Tracer HL; Loh YP
    Neuropeptides; 1993 Sep; 25(3):161-7. PubMed ID: 8247254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey.
    Shridhar S; Farley A; Reid RL; Foster WG; Van Vugt DA
    Toxicol Sci; 2001 Oct; 63(2):181-8. PubMed ID: 11568361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histaminergic activation of the hypothalamic-pituitary-adrenal axis.
    Kjaer A; Larsen PJ; Knigge U; Warberg J
    Endocrinology; 1994 Sep; 135(3):1171-7. PubMed ID: 8070360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the arginine vasopressin gene in response to salt loading in oxytocin gene knockout mice.
    Ozaki Y; Nomura M; Saito J; Luedke CE; Muglia LJ; Matsumoto T; Ogawa S; Ueta Y; Pfaff DW
    J Neuroendocrinol; 2004 Jan; 16(1):39-44. PubMed ID: 14962074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N; Oliver C; Grino M
    J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
    Dakine N; Oliver C; Grino M
    Life Sci; 2000 Oct; 67(23):2827-44. PubMed ID: 11105998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hyperosmotic stimulation and adrenalectomy on vasopressin mRNA levels in the paraventricular and supraoptic nuclei of the hypothalamus: in situ hybridization histochemical analysis using a synthetic oligonucleotide probe.
    Suemaru S; Hashimoto K; Ogasa T; Takao T; Ota Z; Hirakawa M; Kawata M
    Acta Med Okayama; 1990 Oct; 44(5):233-41. PubMed ID: 2260495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.
    Arima H; Aguilera G
    J Neuroendocrinol; 2000 Sep; 12(9):833-42. PubMed ID: 10971808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V; Soriano L; Dallman MF
    J Neuroendocrinol; 2001 May; 13(5):442-52. PubMed ID: 11328455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus.
    Albeck DS; Hastings NB; McEwen BS
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):129-34. PubMed ID: 7854039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.
    Amaya F; Tanaka M; Hayashi S; Tanaka Y; Ibata Y
    Neuroendocrinology; 2001 Mar; 73(3):185-93. PubMed ID: 11307037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CRH gene expression and downregulation of arginine vasopressin gene expression in the hypothalamus of bilateral nephrectomized rats.
    Nomura M; Serino R; Yamamoto Y; Ozaki Y; Saito J; Matsumoto T; Yamashita H; Ueta Y
    Life Sci; 2002 Dec; 72(4-5):501-9. PubMed ID: 12467890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
    Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement.
    Ogasa T; Hashimoto K; Suemaru S; Kageyama J; Ota Z
    Brain Res; 1992 Jun; 583(1-2):45-53. PubMed ID: 1504843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice.
    Nomura M; Saito J; Ueta Y; Muglia LJ; Pfaff DW; Ogawa S
    J Neuroendocrinol; 2003 Nov; 15(11):1054-61. PubMed ID: 14622435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
    van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
    J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
    Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
    J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.